Release Date: June 8, 2012
U.S. Food and Drug Administration (FDA)
The purpose of this Notice is to correct contact information in the letter of intent section and the Financial/Grants Management contact.
Now Reads:
Letter of Intent |
The letter of intent should be emailed to: Yemisi Akinneye |
Should Read:
Letter of Intent |
The letter of intent should be sent by email to: Wendy Campbell, Project Officer |
Now Reads:
Financial/Grants Management Contact(s) |
Yemisi Akinneye |
Should Read:
Financial/Grants Management Contact(s) |
Dan Lukash |
All other aspects of the FOA remain unchanged.
Please direct all inquiries to:
Dan Lukash
Grants Management Specialist
U.S. Food and Drug Administration
Office of Acquisition and Grants Services
5630 Fishers Lane Room 1071
Rockville, MD 20857
TEL: 301-827-6771
FAX: 301-827-1044
EMAIL: [email protected]